AOU Consorziale Policlinico di Bari
Bari, BA 70124
0 studies enrolling now · 5 studies all time
What they study most
Cardiovascular Disease, Diabetes Mellitus, Type 2, Diabetic Nephropathy, Obesity
Studies at this site
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight — Running, not enrolling
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed